Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 8Recruiting 5Active not recruiting 2Withdrawn 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 90Nasopharyngeal Carcinoma 53Thyroid Neoplasms 29Mouth Neoplasms 24Thyroid Cancer, Papillary 15Oropharyngeal Neoplasms 13Neoplasm Metastasis 13Carcinoma, Squamous Cell 13Carcinoma, Non-Small-Cell Lung 13Laryngeal Neoplasms 12Neoplasms 11Uterine Cervical Neoplasms 10Colorectal Neoplasms 10Breast Neoplasms 10Thyroid Nodule 8Nasopharyngeal Neoplasms 7Melanoma 7Hypopharyngeal Neoplasms 7Thyroid Diseases 6Ovarian Neoplasms 6Lung Neoplasms 6Triple Negative Breast Neoplasms 5Sarcoma 5Recurrence 5Esophageal Neoplasms 5Endometrial Neoplasms 5Carcinoma, Renal Cell 5Thyroid Carcinoma, Anaplastic 4Stomach Neoplasms 4

Interventions

pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lip Neoplasms × Head & Neck × Clear all
NCT07552558 2026-06-03

Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)

Washington University School of Medicine

Phase 1/2 Not yet recruiting
45 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Jaw Neoplasms, Laryngeal Neoplasms, Lip Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡